Omega-3 fatty acids in critical illness

Nutrition Reviews

Volumn 68, Issue 9, 2010, Pages 531-541

  Martin, Julie M ^a   Stapleton, Renee D ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Acute lung injury; Critical illness; Fish oil; Mechanical ventilation; Omega 3 fatty acids; Sepsis

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FISH OIL; GAMMA LINOLENIC ACID; HYDROXYL GROUP; I KAPPA B; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE; LINOLEIC ACID; LINOLENIC ACID; LINSEED OIL; LIPID EMULSION; LIPOXIN; MYRISTIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; PROSTAGLANDIN; SAFFLOWER OIL; SOYBEAN OIL; STEARIC ACID; SUNFLOWER OIL; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA; VEGETABLE OIL;

ABDOMINAL SURGERY; ACUTE LUNG INJURY; ANTIINFLAMMATORY ACTIVITY; BIOSYNTHESIS; CHEMICAL STRUCTURE; CORN; CRITICAL ILLNESS; CYTOKINE RELEASE; DIET SUPPLEMENTATION; ENTERIC FEEDING; ENZYME INHIBITION; FATTY ACID SYNTHESIS; FOOD COMPOSITION; HEAD INJURY; HUMAN; INFLAMMATION; LINSEED; MACROPHAGE; MONOCYTE; MORTALITY; MULTIPLE TRAUMA; NEUTROPHIL; PARENTERAL NUTRITION; PATIENT CARE; RAPESEED; REVIEW; SAFFLOWER; SEPSIS; SUNFLOWER; VITAMIN SUPPLEMENTATION;

CRITICAL CARE; CRITICAL ILLNESS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT;

EID: 77956624243     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2010.00313.x     Document Type: Review

References (81)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303.
2. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: A clinical review. Lancet. 2007;369:1553.
3. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685.
4. Bernard GR, Artigas A, Brigham KL, et al. The American- European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818.
5. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334.
6. Hudson LD,Milberg JA, Anardi D, et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151:293.
7. Stapleton RD, Wang BM, Hudson LD, et al. Causes and timing of death in patients with ARDS. Chest. 2005;128:525.
8. Calder PC. N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids. 2003;38:343.
9. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70(Suppl):S560.
10. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose-response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83(Suppl): S1467.
11. Simopoulos AP. Evolutionary aspects of diet, the omega-6/ omega-3 ratio and genetic variation: Nutritional implications for chronic diseases. Biomed Pharmacother. 2006;60: 502.
12. Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993;103:565.
13. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771.
14. Parsons PE. Mediators and mechanisms of acute lung injury. Clin Chest Med. 2000;21:467.
15. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33:1.
16. Ware LB, Matthay MA, Parsons PE, et al. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2007;35:1821.
17. Chapkin RS, KimW, Lupton JR, et al. Dietary docosahexaenoic and eicosapentaenoic acid: Emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids. 2009; 81:187.
18. Bulger EM, Maier RV. Lipid mediators in the pathophysiology of critical illness. Crit Care Med. 2000;28:N27.
19. Palombo JD, Lydon EE, Chen PL, et al. Fatty acid composition of lung, macrophage and surfactant phospholipids after short-term enteral feeding with n-3 lipids. Lipids. 1994; 29:643.
20. Tilley SL, Coffman TM, Koller BH. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest. 2001;108:15.
21. Harris SG, Padilla J, Koumas L, et al. Prostaglandins as modulators of immunity. Trends Immunol. 2002;23:144.
22. Petrak RA, Balk RA, Bone RC. Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure. Crit Care Clin. 1989;5:303.
23. Marangoni F, Angeli MT, Colli S, et al. Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta. 1993;1210:55.
24. Lee TH, Menica-Huerta JM, Shih C, et al. Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product. J Biol Chem. 1984;259:2383.
25. Golman DW, Pickett WC, Goetzl EJ. Human neutrophil chemotactic and degranulating activites of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem Biophys Res Commun. 1983;117:282.
26. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 1985;312:1217.
27. Whelan J, Broughton KS, Kinsella JE. The comparative effects of dietary alpha-linolenic acid and fish oil on 4- and 5-series leukotriene formation in vivo. Lipids. 1991;26:119.
28. Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta. 1984;779:89.
29. Murphy MG. Dietary fatty acids and membrane protein function. J Nutr Biochem. 1990;1:68.
30. Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids. 2008;79:101.
31. Jury EC, Flores-Borja F, Kabouridis PS. Lipid rafts in T cell signalling and disease. Semin Cell Dev Biol. 2007;18:608.
32. Wassall SR, Stillwell W. Docosahexaenoic acid domains: The ultimate non-raft membrane domain. Chem Phys Lipids. 2008;153:57.
33. Chapkin RS, Wang N, Fan YY, et al. Docosahexaenoic acid alters the size and distribution of cell surface microdomains. Biochim Biophys Acta. 2008;1778:466.
34. Kumar A, Takada Y, Boriek AM, et al. Nuclear factor-kappaB: Its role in health and disease. J Mol Med. 2004;82:434.
35. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8: 49.
36. Lo CJ, Chiu KC, Fu M, et al. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res. 1999;82:216.
37. Novak TE, Babcock TA, Jho DH, et al. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol. 2003;284:L84.
38. Zhao Y, Joshi-Barve S, Barve S, et al. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr. 2004;23:71.
39. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52:885.
40. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007;28:176.
41. Serhan CN, Clish CB, Brannon J, et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med. 2000;192:1197.
42. Serhan CN, Hong S, Gronert K, et al. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002;196:1025.
43. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349.
44. Levy BD, Kohli P, Gotlinger K, et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol. 2007;178:496.
45. Haworth O, Cernadas M, Yang R, et al. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol. 2008;9:873.
46. Arita M, Yoshida M, Hong S, et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA. 2005;102:7671.
47. Arita M, Bianchini F, Aliberti J, et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005;201: 713.
48. Mayer K, Seeger W. Fish oil in critical illness. Curr Opin Clin Nutr Metab Care. 2008;11:121.
49. Singer P, Shapiro H. Enteral omega-3 in acute respiratory distress syndrome. Curr Opin Clin Nutr Metab Care. 2009;12:123.
50. Pontes-Arruda A, Demichele S, Seth A, et al. The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: A meta-analysis of outcome data. J Parenter Enteral Nutr. 2008;32:596.
51. Mancuso P, Whelan J, DeMichele SJ, et al. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med. 1997;25:1198.
52. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999;27:1409.
53. Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34:1033.
54. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006;34:2325.
55. Palombo JD, DeMichele SJ, Lydon EE, et al. Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous enteral feeding with n-3 and gamma-linolenic fatty acids. Am J Clin Nutr. 1996;63:208.
56. Mancuso P, Whelan J, DeMichele SJ, et al. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med. 1997;25:523.
57. Palombo JD, DeMichele SJ, Lydon E, et al. Cyclic versus continuous enteral feeding with omega-3 and gamma-linolenic fatty acids: Effects on modulation of phospholipid fatty acids in rat lung and liver immune cells. J Parenter Enteral Nutr. 1997;21:123.
58. Palombo JD, DeMichele SJ, Boyce PJ, et al. Metabolism of dietary alpha-linolenic acid versus eicosapentaenoic acid in rat immune cell phospholipids during endotoxemia. Lipids. 1998;33:1099.
59. Palombo JD, DeMichele SJ, Boyce PJ, et al. Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats. Crit Care Med. 1999;27:1908.
60. Elamin M, Hughes LF, Drew D. Effect of enteral nutrition with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants reduced alveolar inflammatory mediators and proteins influx in patients with acute respiratory distress syndrome (ARDS). Chest. 2005;128(Suppl):S225.
61. Moran V. Effect of an enteral feedin with eicosapentaenoic and gamma-linolenic acids on the outcome of mechanically ventilated critically ill septic patients. Crit Care Med. 2006;34:A70.
62. Heyland DK. Nutrition Clinical Practice Guidelines 4.1(b). Composition of enteral nutrition: Fish oils. 2009; Available at: Http:www. criticalcarenutrition.com/docs/cpg/ 4.1bfish%20oils-FINAL.pdf. Accessed 2 August 2010.
63. Pacht ER, DeMichele SJ, Nelson JL, et al. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med. 2003;31:491.
64. Nelson JL, DeMichele SJ, Pacht ER, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. J Parenter Enteral Nutr. 2003;27:98.
65. Calder PC. Immunonutrition in surgical and critically ill patients. Br J Nutr. 2007;98(Suppl 1):S133.
66. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: A systematic review and analysis of the literature. Intensive Care Med. 2008;34:1980.
67. Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286:944.
68. Rice T, for the NHLBI ARDS Network. Trial of omega-3 fatty acid, gamma-linolenic acid and antioxidant supplemention in the management of acute lung injury (Omega). Paper presented at: American Thoracic Society International Conference; May, 18, 2009, 2009; San Diego, California.
69. Stapleton RD, Martin TR, Gundel SJ, et al. A phase II, randomized, double-blind, placebo-controlled, safety and efficacy study of fish oil (eicosapentaenoic acid and docosahexanoic acid) on lung and systemic inflammation in patients with acute lung injury. Am J Respir Crit Care Med. 2009; 179:A2169.(Abstr.).
70. Suchner U, Katz DP, Furst P, et al. Impact of sepsis, lung injury, and the role of lipid infusion on circulating prostacyclin and thromboxane A(2). Intensive Care Med. 2002;28:122.
71. Calder PC. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc. 2009;68:252.
72. McCowen KC, Friel C, Sternberg J, et al. Hypocaloric total parenteral nutrition: Effectiveness in prevention of hyperglycemia and infectious complications - a randomized clinical trial. Crit Care Med. 2000;28:3606.
73. Battistella FD,Widergren JT, Anderson JT, et al. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma. 1997;43:52.
74. Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support inmechanically ventilated, critically ill adult patients. J Parenter Enteral Nutr. 2003;27:355.
75. Mayer K, Gokorsch S, Fegbeutel C, et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med. 2003;167:1321.
76. Mayer K, Fegbeutel C, Hattar K, et al. Omega-3 versus omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: Impact on plasma fatty acids and lipid mediator generation. Intensive Care Med. 2003;29:1472.
77. Heller AR, Rossler S, Litz RJ, et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med. 2006;34:972.
78. Wang X, Li W, Li N, et al. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: A randomized and controlled study. J Parenter Enteral Nutr. 2008;32:236.
79. Friesecke S, Lotze C, Kohler J, et al. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: A randomised controlled trial. Intensive Care Med. 2008; 34:1411.
80. Tsekos E, Reuter C, Stehle P, et al. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr. 2004;23:325.
81. Preiser JC, Chiolero R,Wernerman J. Nutritional papers in ICU patients: What lies between the lines? Intensive Care Med. 2003;29:156.